Telescope Innovations (FRA:J4U) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:J4U Telescope Innovations Corp FRA:J4U
20 GF Score
Price €0.37
GF Value €0.32
Valuation Modestly Overvalued
! 1 Warning Sign
View Full Analysis

What is Telescope Innovations FFO?

FFO (Funds from operations) only applies to REITs.

FRA:J4U
20GF Score
Telescope Innovations Corp FRA:J4U
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Telescope Innovations (FRA:J4U) Overvalued in 2026?

Based on GuruFocus' analysis, Telescope Innovations stock appears to be overvalued. The current stock price of €0.37 is trading 15% above its estimated GF Value™ of €0.32. GuruFocus considers Telescope Innovations to be Modestly Overvalued.

Key valuation signals for FRA:J4U:

  • FFO:
  • GF Value™: €0.32 vs. price of €0.37 (15% above fair value)
  • GF Score™: 20/100 with 1 warning sign

No single metric tells the full story. See the FRA:J4U stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Telescope Innovations Business Description

Other Exchanges TELIF:USATELI:Canada
Address 2386 East Mall, Suite 301, Vancouver, BC, CAN, V6T 1Z3
Telescope Innovations Corp is a technology company focused on development as a Contract Research Organization (CRO) to develop intellectual property, provide contract research, and build automation products, and operates as a chemical technology company developing scalable manufacturing processes and tools for the pharmaceutical and chemical industry. Its flagship product is the DirectInject-LC system. The Company operates in a single operating segment and generates revenue from three streams: contract research services, grant income, and the sale of automation products, with the majority of revenue derived from automation product sales from customer contracts. It operates in Canada, the United States, Europe, and Asia, with the majority of revenue coming from the United States.
20GF Score

Get the complete analysis for FRA:J4U

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.37
Price
€0.32
GF Value